Funding in, findings out
For any dataset: the NCI award that paid to create it, and the awards that got a published finding out of it afterwards.
TCGA-TGCT
Testicular Germ Cell Tumors
16 awards paid to create it · 9 awards funded work that used it
1. Awards that paid to create this data (6 of 16)
- BIGDATA: Mid-Scale DCM: DA: ESCE: Discovering Molecular Processes · JOSHUA Michael STUART · FY2013–2017
- TCGA Data Analysis Center at Berkeley · PAUL T. SPELLMAN, Terence Paul Speed · FY2009–2016
- Center for Systems Analysis of the Cancer Regulome · ILYA SHMULEVICH · FY2009–2016
- MSKCC Center for Translational Cancer Genomic Analysis · Marc Ladanyi, CHRIS SANDER · FY2009–2016
- The BCM Tumor Genome Characterization Center · RICHARD A GIBBS, David Andrew Wheeler · FY2009–2013
- The Cancer Genome Atlas Data Analysis Center · LYNDA CHIN, GAD A GETZ · FY2009–2016
The best connected are shown.
2. The dataset
3. Articles that used it (3)
4. Awards those articles were funded by (6 of 9)
- Antitumor Assessment · Elisa de Stanchina, FRANCESCA M GANY · FY1985–2026funded 1 of these 3 articles
- Homologous recombination deficiency and beyond in pancreatic cancer: evaluating… · Eileen Mary O'Reilly, Alice Chia- chi Wei · FY2022–2026funded 1 of these 3 articles
- Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity · Vinod P Balachandran, Taha Merghoub · FY2022–2025funded 1 of these 3 articles
- Clinical Protocol and Data Management · Amy S Clark, Sunita Nasta · FY1985–2026funded 1 of these 3 articles
- Inherited genetic variation and predisposition to testicular germ cell tumor · Katherine L. Nathanson · FY2007–2011funded 1 of these 3 articles
- Post genome wide association studies in testicular germ cell tumors · PETER A KANETSKY, Katherine L. Nathanson · FY2012–2024funded 1 of these 3 articles
The best connected are shown.
Awards that paid to create this data
Credited on the dataset's own marker paper.
| Award | Project | Evidence |
|---|---|---|
| R01CA180778 R01FY2013–2017$3.5M | BIGDATA: Mid-Scale DCM: DA: ESCE: Discovering Molecular Processes | API |
| U24CA143799 U24FY2009–2016$4.9M | TCGA Data Analysis Center at Berkeley | API |
| U24CA143835 U24FY2009–2016$10.6M | Center for Systems Analysis of the Cancer Regulome | API |
| U24CA143840 U24FY2009–2016$11.5M | MSKCC Center for Translational Cancer Genomic Analysis | API |
| U24CA143843 U24FY2009–2013$9.5M | The BCM Tumor Genome Characterization Center | API |
| U24CA143845 U24FY2009–2016$16.0M | The Cancer Genome Atlas Data Analysis Center | API |
| U24CA143848 U24FY2009–2016$20.8M | Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing | API |
| U24CA143858 U24FY2009–2016$8.9M | UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC) | API |
| U24CA143866 U24FY2009–2015$10.9M | Cancer transcriptome characterization using massively parallel DNA sequencing | API |
| U24CA143867 U24FY2009–2016$17.0M | Genome Characterization Center (GCC) | API |
| U24CA143882 U24FY2009–2016$13.3M | The USC-JHU Cancer Epigenome Characterization Center | API |
| U24CA143883 U24FY2009–2016$10.6M | Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC) | API |
| U24CA144025 U24FY2009–2016$14.0M | Harvard Genome Characterization Center | API |
| U24CA210949 U24FY2016–2020$1.9M | Batch effects in molecular profiling data on cancers: detection, quantitation, interpretation, and correction | API |
| U24CA210969 U24FY2016–2020$2.5M | Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC) | API |
| U24CA210988 U24FY2016–2020$2.1M | RNA sequencing analysis of Cancer | API |
Awards that funded work using this data
3 of 10 traced articles report an NCI award.
| Award | Project | Articles it is credited on | Evidence |
|---|---|---|---|
| P30CA008748 P30FY1985–2026$717.7M | Antitumor Assessment | API | |
| P50CA257881 P50FY2022–2026$23.8M | Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives | API | |
| R01CA262516 R01FY2022–2025$2.8M | Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity | API | |
| P30CA016520 P30FY1985–2026$415.8M | Clinical Protocol and Data Management | API | |
| R01CA114478 R01FY2007–2011$3.1M | Inherited genetic variation and predisposition to testicular germ cell tumor | API | |
| U01CA164947 U01FY2012–2024$11.7M | Post genome wide association studies in testicular germ cell tumors | API | |
| P30CA124435 P30FY2007–2026$125.5M | Biostatistics | API | |
| R01CA198291 R01FY2016–2020$2.4M | Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer | API | |
| T32CA009302 T32FY1985–2026$27.8M | Leveraging innovative technologies in basic and clinical cancer research | API |
Awards that maintain or redistribute this data
Resource and center grants credited on articles that used the data. Kept out of the flow above because they pay for the pipes, not for a cohort or a finding.
| Award | Project | Evidence |
|---|---|---|
| P30CA008748 P30FY1985–2026$717.7M | Antitumor Assessment | API |
| P30CA016520 P30FY1985–2026$415.8M | Clinical Protocol and Data Management | API |
| P30CA124435 P30FY2007–2026$125.5M | Biostatistics | API |
| P50CA257881 P50FY2022–2026$23.8M | Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives | API |
| U01CA164947 U01FY2012–2024$11.7M | Post genome wide association studies in testicular germ cell tumors | API |
Where the links come from
NIH RePORTER maps a PMID to the awards that reported it. On a dataset’s marker paper that gives the awards which created it; on an article that used the data, the awards which funded that use.
The two sides are not measured alike. Generation is complete: a dataset has one marker paper and every award on it is resolved. Reuse is a sample - the articles using a dataset can number in the thousands, and only the few dozen strongest are retrieved and looked up. Every award shown here funded reuse; there are more that are not shown.
How far it reaches
283 datasets have an award credited with creating them, 80 with using them, and 31 both.
What is missing
No citable accession means no traceable articles; no authoritative marker paper means no attributable generation award. Absence is a gap in the record. Methods.
Start from an award instead, and see every dataset it touches.